Monte Rosa Therapeutics Inc (GLUE)

Other Income/Expenses (Net)

$17.88M

TTM · Period ending: · USD

GLUE logo

GLUE Other Income/Expenses (Net)

Latest reported$17.88M
GLUE TTM Other Income/Expenses (Net) (-$7.87M → $17.88M)
High-resolution chart · PNG

GLUE other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Monte Rosa Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
17,880,000
16,397,000
14,485,000
13,443,000
13,465,000
11,591,000
10,982,000
9,974,000
9,490,000
9,139,000
8,298,000
8,416,000
7,205,000
5,734,000
3,883,000
2,123,000
1,110,000
66,000
-1,076,000
-8,743,000
-8,946,000
-8,632,000
-7,869,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.